In addition, more recently, it has been reported that loss of POB1 expression in prostate cancer cells results in deregulation of growth factor signaling, while an increase of POB1 expression has been correlated with silencing of EGF signaling. The gene discussed is REPS2; the disease is prostate carcinoma.